nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—NFKBIA—psoriasis	0.277	0.693	CbGaD
Acetylsalicylic acid—migraine—Prednisone—psoriasis	0.127	0.508	CpDpCtD
Acetylsalicylic acid—osteoarthritis—Prednisone—psoriasis	0.123	0.492	CpDpCtD
Acetylsalicylic acid—TP53—psoriasis	0.122	0.307	CbGaD
Acetylsalicylic acid—ALB—Acitretin—psoriasis	0.0184	0.0954	CbGbCtD
Acetylsalicylic acid—CYP2C8—Tazarotene—psoriasis	0.018	0.0933	CbGbCtD
Acetylsalicylic acid—PTGS2—Triamcinolone—psoriasis	0.0137	0.0708	CbGbCtD
Acetylsalicylic acid—PTGS2—Betamethasone—psoriasis	0.0117	0.0608	CbGbCtD
Acetylsalicylic acid—SLC22A7—Methotrexate—psoriasis	0.00954	0.0495	CbGbCtD
Acetylsalicylic acid—ALB—Mycophenolate mofetil—psoriasis	0.00861	0.0447	CbGbCtD
Acetylsalicylic acid—CYP2C8—Cholecalciferol—psoriasis	0.00768	0.0398	CbGbCtD
Acetylsalicylic acid—SLC22A6—Cyclosporine—psoriasis	0.00766	0.0398	CbGbCtD
Acetylsalicylic acid—ALB—Prednisone—psoriasis	0.00689	0.0357	CbGbCtD
Acetylsalicylic acid—PTGS2—Dexamethasone—psoriasis	0.00682	0.0354	CbGbCtD
Acetylsalicylic acid—CYP2C8—Mycophenolate mofetil—psoriasis	0.00666	0.0345	CbGbCtD
Acetylsalicylic acid—CYP2C19—Cholecalciferol—psoriasis	0.00644	0.0334	CbGbCtD
Acetylsalicylic acid—HSPA5—skeletal joint—psoriasis	0.00597	0.189	CbGeAlD
Acetylsalicylic acid—CYP2C9—Cholecalciferol—psoriasis	0.00535	0.0278	CbGbCtD
Acetylsalicylic acid—CYP2C8—Hydrocortisone—psoriasis	0.00534	0.0277	CbGbCtD
Acetylsalicylic acid—CYP2C8—Cyclosporine—psoriasis	0.00504	0.0262	CbGbCtD
Acetylsalicylic acid—ABCB1—Mycophenolate mofetil—psoriasis	0.00451	0.0234	CbGbCtD
Acetylsalicylic acid—CYP2C19—Prednisone—psoriasis	0.00446	0.0232	CbGbCtD
Acetylsalicylic acid—CYP2C19—Cyclosporine—psoriasis	0.00423	0.0219	CbGbCtD
Acetylsalicylic acid—SLC22A6—Methotrexate—psoriasis	0.00406	0.021	CbGbCtD
Acetylsalicylic acid—ABCB1—Betamethasone—psoriasis	0.00387	0.02	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisolone—psoriasis	0.00381	0.0198	CbGbCtD
Acetylsalicylic acid—ABCB1—Hydrocortisone—psoriasis	0.00362	0.0188	CbGbCtD
Acetylsalicylic acid—ABCB1—Prednisone—psoriasis	0.0036	0.0187	CbGbCtD
Acetylsalicylic acid—TP53—manus—psoriasis	0.0036	0.114	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—psoriasis	0.00352	0.112	CbGeAlD
Acetylsalicylic acid—CYP2C9—Cyclosporine—psoriasis	0.00352	0.0182	CbGbCtD
Acetylsalicylic acid—ALB—Methotrexate—psoriasis	0.00345	0.0179	CbGbCtD
Acetylsalicylic acid—ABCB1—Cyclosporine—psoriasis	0.00341	0.0177	CbGbCtD
Acetylsalicylic acid—CYP2C8—Dexamethasone—psoriasis	0.00332	0.0172	CbGbCtD
Acetylsalicylic acid—TP53—skin epidermis—psoriasis	0.00302	0.0956	CbGeAlD
Acetylsalicylic acid—CYP2C19—Dexamethasone—psoriasis	0.00279	0.0145	CbGbCtD
Acetylsalicylic acid—CYP2C9—Dexamethasone—psoriasis	0.00232	0.012	CbGbCtD
Acetylsalicylic acid—ABCB1—Dexamethasone—psoriasis	0.00225	0.0117	CbGbCtD
Acetylsalicylic acid—TP53—endothelium—psoriasis	0.00219	0.0694	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—psoriasis	0.00216	0.0683	CbGeAlD
Acetylsalicylic acid—ABCB1—Methotrexate—psoriasis	0.00181	0.00937	CbGbCtD
Acetylsalicylic acid—PTGS2—skeletal joint—psoriasis	0.00119	0.0378	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—psoriasis	0.000935	0.0296	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—psoriasis	0.00092	0.0292	CbGeAlD
Acetylsalicylic acid—PTGS2—synovial membrane of synovial joint—psoriasis	0.000907	0.0287	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—psoriasis	0.000901	0.0286	CbGeAlD
Acetylsalicylic acid—TP53—tendon—psoriasis	0.000712	0.0226	CbGeAlD
Acetylsalicylic acid—NFKBIA—tendon—psoriasis	0.000701	0.0222	CbGeAlD
Acetylsalicylic acid—HSPA5—tendon—psoriasis	0.000686	0.0217	CbGeAlD
Acetylsalicylic acid—RPS6KA3—tendon—psoriasis	0.000584	0.0185	CbGeAlD
Acetylsalicylic acid—PTGS2—skin epidermis—psoriasis	0.000582	0.0184	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—psoriasis	0.000567	0.018	CbGeAlD
Acetylsalicylic acid—EDNRA—tendon—psoriasis	0.000475	0.0151	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—psoriasis	0.000442	0.014	CbGeAlD
Acetylsalicylic acid—IKBKB—tendon—psoriasis	0.000431	0.0137	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—psoriasis	0.000422	0.0134	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000192	0.108	CbGdCrCtD
Acetylsalicylic acid—PTGS1—skin of body—psoriasis	0.000189	0.00597	CbGeAlD
Acetylsalicylic acid—PTGS2—skin of body—psoriasis	0.00018	0.00571	CbGeAlD
Acetylsalicylic acid—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000154	0.0869	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.00015	0.0844	CbGdCrCtD
Acetylsalicylic acid—PTGS1—tendon—psoriasis	0.000144	0.00455	CbGeAlD
Acetylsalicylic acid—PTGS2—tendon—psoriasis	0.000137	0.00435	CbGeAlD
Acetylsalicylic acid—TP53—Testosterone—Hydrocortisone—psoriasis	0.000118	0.0665	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000116	0.0655	CbGdCrCtD
Acetylsalicylic acid—TP53—Testosterone—Prednisolone—psoriasis	9.91e-05	0.0559	CbGdCrCtD
Acetylsalicylic acid—TP53—Danazol—Hydrocortisone—psoriasis	9.57e-05	0.054	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	9.3e-05	0.0524	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	9.3e-05	0.0524	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	9.04e-05	0.0509	CbGdCrCtD
Acetylsalicylic acid—TP53—Norethindrone—Hydrocortisone—psoriasis	8.62e-05	0.0486	CbGdCrCtD
Acetylsalicylic acid—TP53—Danazol—Prednisone—psoriasis	8.24e-05	0.0465	CbGdCrCtD
Acetylsalicylic acid—Feeling abnormal—Hydroxyurea—psoriasis	7.73e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Shock—Mycophenolic acid—psoriasis	7.73e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mycophenolic acid—psoriasis	7.69e-05	0.00143	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mycophenolic acid—psoriasis	7.67e-05	0.00142	CcSEcCtD
Acetylsalicylic acid—Vomiting—Acitretin—psoriasis	7.6e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mycophenolic acid—psoriasis	7.6e-05	0.00141	CcSEcCtD
Acetylsalicylic acid—Vomiting—Fluocinolone Acetonide—psoriasis	7.58e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Rash—Acitretin—psoriasis	7.53e-05	0.0014	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Acitretin—psoriasis	7.53e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Triamcinolone—psoriasis	7.53e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Rash—Fluocinolone Acetonide—psoriasis	7.51e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Fluocinolone Acetonide—psoriasis	7.51e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Triamcinolone—psoriasis	7.49e-05	0.00139	CcSEcCtD
Acetylsalicylic acid—Anaemia—Cyclosporine—psoriasis	7.2e-05	0.00133	CcSEcCtD
Acetylsalicylic acid—Agitation—Cyclosporine—psoriasis	7.16e-05	0.00133	CcSEcCtD
Acetylsalicylic acid—Angioedema—Cyclosporine—psoriasis	7.12e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Nausea—Acitretin—psoriasis	7.1e-05	0.00132	CcSEcCtD
Acetylsalicylic acid—Nausea—Fluocinolone Acetonide—psoriasis	7.08e-05	0.00131	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Dexamethasone—psoriasis	7.02e-05	0.0396	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Betamethasone—psoriasis	7.02e-05	0.0396	CbGdCrCtD
Acetylsalicylic acid—Anaemia—Mycophenolate mofetil—psoriasis	7.02e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mycophenolic acid—psoriasis	7e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Vertigo—Cyclosporine—psoriasis	7e-05	0.0013	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mycophenolic acid—psoriasis	6.99e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Agitation—Mycophenolate mofetil—psoriasis	6.98e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Cyclosporine—psoriasis	6.97e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Angioedema—Mycophenolate mofetil—psoriasis	6.94e-05	0.00129	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mycophenolic acid—psoriasis	6.92e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Hydroxyurea—psoriasis	6.91e-05	0.00128	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluocinonide—Triamcinolone—psoriasis	6.86e-05	0.0387	CbGdCrCtD
Acetylsalicylic acid—TP53—Levonorgestrel—Hydrocortisone—psoriasis	6.86e-05	0.0387	CbGdCrCtD
Acetylsalicylic acid—Haemoglobin—Dexamethasone—psoriasis	6.83e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Betamethasone—psoriasis	6.83e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Vertigo—Mycophenolate mofetil—psoriasis	6.83e-05	0.00127	CcSEcCtD
Acetylsalicylic acid—Syncope—Mycophenolate mofetil—psoriasis	6.81e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Mycophenolate mofetil—psoriasis	6.8e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Dexamethasone—psoriasis	6.79e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Betamethasone—psoriasis	6.79e-05	0.00126	CcSEcCtD
Acetylsalicylic acid—Convulsion—Cyclosporine—psoriasis	6.75e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Hypertension—Cyclosporine—psoriasis	6.72e-05	0.00125	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Mycophenolate mofetil—psoriasis	6.68e-05	0.00124	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Cyclosporine—psoriasis	6.63e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Chest pain—Cyclosporine—psoriasis	6.63e-05	0.00123	CcSEcCtD
Acetylsalicylic acid—Convulsion—Mycophenolate mofetil—psoriasis	6.58e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Hypertension—Mycophenolate mofetil—psoriasis	6.56e-05	0.00122	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisolone—psoriasis	6.48e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mycophenolic acid—psoriasis	6.47e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Mycophenolate mofetil—psoriasis	6.47e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Chest pain—Mycophenolate mofetil—psoriasis	6.47e-05	0.0012	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Hydroxyurea—psoriasis	6.42e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Confusional state—Cyclosporine—psoriasis	6.41e-05	0.00119	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisolone—psoriasis	6.37e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Cyclosporine—psoriasis	6.36e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisolone—psoriasis	6.36e-05	0.00118	CcSEcCtD
Acetylsalicylic acid—Angioedema—Hydrocortisone—psoriasis	6.32e-05	0.00117	CcSEcCtD
Acetylsalicylic acid—Confusional state—Mycophenolate mofetil—psoriasis	6.25e-05	0.00116	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisolone—psoriasis	6.23e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Cyclosporine—psoriasis	6.22e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Vertigo—Hydrocortisone—psoriasis	6.22e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Syncope—Hydrocortisone—psoriasis	6.21e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Dizziness—Hydroxyurea—psoriasis	6.2e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Mycophenolate mofetil—psoriasis	6.2e-05	0.00115	CcSEcCtD
Acetylsalicylic acid—Asthma—Methotrexate—psoriasis	6.18e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Cyclosporine—psoriasis	6.14e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisolone—psoriasis	6.14e-05	0.00114	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisolone—psoriasis	6.12e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Shock—Mycophenolate mofetil—psoriasis	6.1e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Hydrocortisone—psoriasis	6.08e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Mycophenolate mofetil—psoriasis	6.07e-05	0.00113	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Mycophenolate mofetil—psoriasis	6.05e-05	0.00112	CcSEcCtD
Acetylsalicylic acid—Convulsion—Hydrocortisone—psoriasis	6e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Mycophenolate mofetil—psoriasis	5.99e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Hypertension—Hydrocortisone—psoriasis	5.98e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Vomiting—Hydroxyurea—psoriasis	5.96e-05	0.00111	CcSEcCtD
Acetylsalicylic acid—Angioedema—Triamcinolone—psoriasis	5.96e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Prednisone—psoriasis	5.95e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Prednisone—psoriasis	5.92e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Rash—Hydroxyurea—psoriasis	5.92e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Hydroxyurea—psoriasis	5.91e-05	0.0011	CcSEcCtD
Acetylsalicylic acid—Vertigo—Triamcinolone—psoriasis	5.86e-05	0.00109	CcSEcCtD
Acetylsalicylic acid—Syncope—Triamcinolone—psoriasis	5.84e-05	0.00108	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisolone—psoriasis	5.78e-05	0.00107	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Triamcinolone—psoriasis	5.73e-05	0.00106	CcSEcCtD
Acetylsalicylic acid—Shock—Prednisolone—psoriasis	5.69e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Cyclosporine—psoriasis	5.67e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Somnolence—Cyclosporine—psoriasis	5.65e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Hydrocortisone—psoriasis	5.65e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Convulsion—Triamcinolone—psoriasis	5.65e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisolone—psoriasis	5.65e-05	0.00105	CcSEcCtD
Acetylsalicylic acid—Hypertension—Triamcinolone—psoriasis	5.63e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Cyclosporine—psoriasis	5.6e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisolone—psoriasis	5.59e-05	0.00104	CcSEcCtD
Acetylsalicylic acid—Nausea—Hydroxyurea—psoriasis	5.57e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mycophenolic acid—psoriasis	5.56e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Shock—Hydrocortisone—psoriasis	5.56e-05	0.00103	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Mycophenolate mofetil—psoriasis	5.53e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Hydrocortisone—psoriasis	5.51e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Somnolence—Mycophenolate mofetil—psoriasis	5.51e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Drowsiness—Methotrexate—psoriasis	5.51e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Flushing—Prednisone—psoriasis	5.49e-05	0.00102	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Hydrocortisone—psoriasis	5.46e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Mycophenolate mofetil—psoriasis	5.46e-05	0.00101	CcSEcCtD
Acetylsalicylic acid—Angioedema—Betamethasone—psoriasis	5.4e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Angioedema—Dexamethasone—psoriasis	5.4e-05	0.001	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mycophenolic acid—psoriasis	5.38e-05	0.000996	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Triamcinolone—psoriasis	5.32e-05	0.000986	CcSEcCtD
Acetylsalicylic acid—Vertigo—Betamethasone—psoriasis	5.31e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Vertigo—Dexamethasone—psoriasis	5.31e-05	0.000985	CcSEcCtD
Acetylsalicylic acid—Syncope—Dexamethasone—psoriasis	5.3e-05	0.000983	CcSEcCtD
Acetylsalicylic acid—Syncope—Betamethasone—psoriasis	5.3e-05	0.000983	CcSEcCtD
Acetylsalicylic acid—Sweating—Methotrexate—psoriasis	5.28e-05	0.000979	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Cyclosporine—psoriasis	5.24e-05	0.000971	CcSEcCtD
Acetylsalicylic acid—Shock—Triamcinolone—psoriasis	5.23e-05	0.00097	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Dexamethasone—psoriasis	5.2e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Betamethasone—psoriasis	5.2e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Dizziness—Mycophenolic acid—psoriasis	5.2e-05	0.000963	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Triamcinolone—psoriasis	5.19e-05	0.000962	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Triamcinolone—psoriasis	5.14e-05	0.000953	CcSEcCtD
Acetylsalicylic acid—Convulsion—Dexamethasone—psoriasis	5.12e-05	0.00095	CcSEcCtD
Acetylsalicylic acid—Convulsion—Betamethasone—psoriasis	5.12e-05	0.00095	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Mycophenolate mofetil—psoriasis	5.11e-05	0.000947	CcSEcCtD
Acetylsalicylic acid—Hypertension—Dexamethasone—psoriasis	5.11e-05	0.000946	CcSEcCtD
Acetylsalicylic acid—Hypertension—Betamethasone—psoriasis	5.11e-05	0.000946	CcSEcCtD
Acetylsalicylic acid—Urticaria—Cyclosporine—psoriasis	5.05e-05	0.000936	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mycophenolic acid—psoriasis	5e-05	0.000926	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Hydrocortisone—psoriasis	4.97e-05	0.000922	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Methotrexate—psoriasis	4.97e-05	0.000921	CcSEcCtD
Acetylsalicylic acid—Rash—Mycophenolic acid—psoriasis	4.95e-05	0.000918	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mycophenolic acid—psoriasis	4.95e-05	0.000917	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Methotrexate—psoriasis	4.94e-05	0.000916	CcSEcCtD
Acetylsalicylic acid—Urticaria—Mycophenolate mofetil—psoriasis	4.93e-05	0.000913	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Dexamethasone—psoriasis	4.83e-05	0.000894	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Betamethasone—psoriasis	4.83e-05	0.000894	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisolone—psoriasis	4.77e-05	0.000883	CcSEcCtD
Acetylsalicylic acid—Anaemia—Prednisone—psoriasis	4.76e-05	0.000882	CcSEcCtD
Acetylsalicylic acid—Shock—Betamethasone—psoriasis	4.75e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Shock—Dexamethasone—psoriasis	4.75e-05	0.00088	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Triamcinolone—psoriasis	4.74e-05	0.000879	CcSEcCtD
Acetylsalicylic acid—Agitation—Prednisone—psoriasis	4.73e-05	0.000877	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dexamethasone—psoriasis	4.73e-05	0.000876	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Betamethasone—psoriasis	4.73e-05	0.000876	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Dexamethasone—psoriasis	4.71e-05	0.000873	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Betamethasone—psoriasis	4.71e-05	0.000873	CcSEcCtD
Acetylsalicylic acid—Angioedema—Prednisone—psoriasis	4.71e-05	0.000872	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Cyclosporine—psoriasis	4.68e-05	0.000868	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Triamcinolone—psoriasis	4.68e-05	0.000868	CcSEcCtD
Acetylsalicylic acid—Nausea—Mycophenolic acid—psoriasis	4.67e-05	0.000865	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Dexamethasone—psoriasis	4.67e-05	0.000865	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Betamethasone—psoriasis	4.67e-05	0.000865	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Hydrocortisone—psoriasis	4.66e-05	0.000863	CcSEcCtD
Acetylsalicylic acid—Vertigo—Prednisone—psoriasis	4.63e-05	0.000857	CcSEcCtD
Acetylsalicylic acid—Syncope—Prednisone—psoriasis	4.62e-05	0.000856	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Methotrexate—psoriasis	4.61e-05	0.000854	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisolone—psoriasis	4.6e-05	0.000852	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.57e-05	0.000847	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Prednisone—psoriasis	4.53e-05	0.000839	CcSEcCtD
Acetylsalicylic acid—Pruritus—Cyclosporine—psoriasis	4.5e-05	0.000833	CcSEcCtD
Acetylsalicylic acid—Urticaria—Hydrocortisone—psoriasis	4.49e-05	0.000832	CcSEcCtD
Acetylsalicylic acid—Convulsion—Prednisone—psoriasis	4.46e-05	0.000827	CcSEcCtD
Acetylsalicylic acid—Hypertension—Prednisone—psoriasis	4.45e-05	0.000824	CcSEcCtD
Acetylsalicylic acid—Pruritus—Mycophenolate mofetil—psoriasis	4.39e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Prednisone—psoriasis	4.38e-05	0.000813	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Triamcinolone—psoriasis	4.38e-05	0.000812	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Cyclosporine—psoriasis	4.35e-05	0.000806	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisolone—psoriasis	4.26e-05	0.00079	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Dexamethasone—psoriasis	4.25e-05	0.000787	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Betamethasone—psoriasis	4.25e-05	0.000787	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Mycophenolate mofetil—psoriasis	4.24e-05	0.000786	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	4.24e-05	0.0239	CbGdCrCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	4.24e-05	0.0239	CbGdCrCtD
Acetylsalicylic acid—Urticaria—Triamcinolone—psoriasis	4.23e-05	0.000783	CcSEcCtD
Acetylsalicylic acid—Dizziness—Cyclosporine—psoriasis	4.2e-05	0.000779	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Prednisone—psoriasis	4.2e-05	0.000779	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Hydrocortisone—psoriasis	4.16e-05	0.000771	CcSEcCtD
Acetylsalicylic acid—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	4.14e-05	0.0233	CbGdCrCtD
Acetylsalicylic acid—Shock—Prednisone—psoriasis	4.14e-05	0.000766	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Prednisone—psoriasis	4.1e-05	0.00076	CcSEcCtD
Acetylsalicylic acid—Dizziness—Mycophenolate mofetil—psoriasis	4.1e-05	0.00076	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Prednisone—psoriasis	4.06e-05	0.000753	CcSEcCtD
Acetylsalicylic acid—Vomiting—Cyclosporine—psoriasis	4.04e-05	0.000749	CcSEcCtD
Acetylsalicylic acid—Rash—Cyclosporine—psoriasis	4.01e-05	0.000743	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Cyclosporine—psoriasis	4e-05	0.000742	CcSEcCtD
Acetylsalicylic acid—Pruritus—Hydrocortisone—psoriasis	4e-05	0.000741	CcSEcCtD
Acetylsalicylic acid—Anaemia—Methotrexate—psoriasis	3.98e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Betamethasone—psoriasis	3.98e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Dexamethasone—psoriasis	3.98e-05	0.000737	CcSEcCtD
Acetylsalicylic acid—Vomiting—Mycophenolate mofetil—psoriasis	3.94e-05	0.000731	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Triamcinolone—psoriasis	3.92e-05	0.000726	CcSEcCtD
Acetylsalicylic acid—Rash—Mycophenolate mofetil—psoriasis	3.91e-05	0.000725	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Mycophenolate mofetil—psoriasis	3.91e-05	0.000724	CcSEcCtD
Acetylsalicylic acid—Vertigo—Methotrexate—psoriasis	3.87e-05	0.000717	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Hydrocortisone—psoriasis	3.87e-05	0.000716	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Methotrexate—psoriasis	3.85e-05	0.000714	CcSEcCtD
Acetylsalicylic acid—Urticaria—Dexamethasone—psoriasis	3.83e-05	0.000711	CcSEcCtD
Acetylsalicylic acid—Urticaria—Betamethasone—psoriasis	3.83e-05	0.000711	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisolone—psoriasis	3.82e-05	0.000709	CcSEcCtD
Acetylsalicylic acid—Nausea—Cyclosporine—psoriasis	3.78e-05	0.0007	CcSEcCtD
Acetylsalicylic acid—Pruritus—Triamcinolone—psoriasis	3.76e-05	0.000697	CcSEcCtD
Acetylsalicylic acid—Dizziness—Hydrocortisone—psoriasis	3.74e-05	0.000692	CcSEcCtD
Acetylsalicylic acid—Convulsion—Methotrexate—psoriasis	3.73e-05	0.000691	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Prednisone—psoriasis	3.7e-05	0.000686	CcSEcCtD
Acetylsalicylic acid—Nausea—Mycophenolate mofetil—psoriasis	3.68e-05	0.000683	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Methotrexate—psoriasis	3.66e-05	0.000679	CcSEcCtD
Acetylsalicylic acid—Chest pain—Methotrexate—psoriasis	3.66e-05	0.000679	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisolone—psoriasis	3.65e-05	0.000676	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisolone—psoriasis	3.64e-05	0.000675	CcSEcCtD
Acetylsalicylic acid—Vomiting—Hydrocortisone—psoriasis	3.59e-05	0.000666	CcSEcCtD
Acetylsalicylic acid—Rash—Hydrocortisone—psoriasis	3.56e-05	0.00066	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Hydrocortisone—psoriasis	3.56e-05	0.000659	CcSEcCtD
Acetylsalicylic acid—Confusional state—Methotrexate—psoriasis	3.54e-05	0.000656	CcSEcCtD
Acetylsalicylic acid—Dizziness—Triamcinolone—psoriasis	3.52e-05	0.000652	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Methotrexate—psoriasis	3.51e-05	0.000651	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Prednisone—psoriasis	3.46e-05	0.000642	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Methotrexate—psoriasis	3.44e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisolone—psoriasis	3.44e-05	0.000637	CcSEcCtD
Acetylsalicylic acid—Pruritus—Dexamethasone—psoriasis	3.41e-05	0.000633	CcSEcCtD
Acetylsalicylic acid—Pruritus—Betamethasone—psoriasis	3.41e-05	0.000633	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Methotrexate—psoriasis	3.4e-05	0.000629	CcSEcCtD
Acetylsalicylic acid—Vomiting—Triamcinolone—psoriasis	3.38e-05	0.000627	CcSEcCtD
Acetylsalicylic acid—Nausea—Hydrocortisone—psoriasis	3.36e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Rash—Triamcinolone—psoriasis	3.35e-05	0.000622	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Triamcinolone—psoriasis	3.35e-05	0.000621	CcSEcCtD
Acetylsalicylic acid—Urticaria—Prednisone—psoriasis	3.34e-05	0.000619	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dexamethasone—psoriasis	3.3e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Betamethasone—psoriasis	3.3e-05	0.000612	CcSEcCtD
Acetylsalicylic acid—Dizziness—Betamethasone—psoriasis	3.19e-05	0.000591	CcSEcCtD
Acetylsalicylic acid—Dizziness—Dexamethasone—psoriasis	3.19e-05	0.000591	CcSEcCtD
Acetylsalicylic acid—Nausea—Triamcinolone—psoriasis	3.16e-05	0.000586	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Methotrexate—psoriasis	3.13e-05	0.00058	CcSEcCtD
Acetylsalicylic acid—Somnolence—Methotrexate—psoriasis	3.12e-05	0.000579	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Prednisone—psoriasis	3.1e-05	0.000574	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Methotrexate—psoriasis	3.09e-05	0.000573	CcSEcCtD
Acetylsalicylic acid—Vomiting—Betamethasone—psoriasis	3.07e-05	0.000569	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dexamethasone—psoriasis	3.07e-05	0.000569	CcSEcCtD
Acetylsalicylic acid—Rash—Betamethasone—psoriasis	3.04e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Rash—Dexamethasone—psoriasis	3.04e-05	0.000564	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Betamethasone—psoriasis	3.04e-05	0.000563	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Dexamethasone—psoriasis	3.04e-05	0.000563	CcSEcCtD
Acetylsalicylic acid—Pruritus—Prednisone—psoriasis	2.97e-05	0.000551	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Methotrexate—psoriasis	2.89e-05	0.000536	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Prednisone—psoriasis	2.88e-05	0.000533	CcSEcCtD
Acetylsalicylic acid—Nausea—Betamethasone—psoriasis	2.87e-05	0.000531	CcSEcCtD
Acetylsalicylic acid—Nausea—Dexamethasone—psoriasis	2.87e-05	0.000531	CcSEcCtD
Acetylsalicylic acid—Urticaria—Methotrexate—psoriasis	2.79e-05	0.000517	CcSEcCtD
Acetylsalicylic acid—Dizziness—Prednisone—psoriasis	2.78e-05	0.000515	CcSEcCtD
Acetylsalicylic acid—Vomiting—Prednisone—psoriasis	2.67e-05	0.000495	CcSEcCtD
Acetylsalicylic acid—Rash—Prednisone—psoriasis	2.65e-05	0.000491	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Prednisone—psoriasis	2.65e-05	0.000491	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Methotrexate—psoriasis	2.59e-05	0.00048	CcSEcCtD
Acetylsalicylic acid—Nausea—Prednisone—psoriasis	2.5e-05	0.000463	CcSEcCtD
Acetylsalicylic acid—Pruritus—Methotrexate—psoriasis	2.49e-05	0.000461	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Methotrexate—psoriasis	2.4e-05	0.000445	CcSEcCtD
Acetylsalicylic acid—Dizziness—Methotrexate—psoriasis	2.32e-05	0.00043	CcSEcCtD
Acetylsalicylic acid—Vomiting—Methotrexate—psoriasis	2.23e-05	0.000414	CcSEcCtD
Acetylsalicylic acid—Rash—Methotrexate—psoriasis	2.21e-05	0.00041	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Methotrexate—psoriasis	2.21e-05	0.00041	CcSEcCtD
Acetylsalicylic acid—Nausea—Methotrexate—psoriasis	2.09e-05	0.000387	CcSEcCtD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	9.72e-06	0.000136	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—JUN—psoriasis	9.71e-06	0.000136	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—psoriasis	9.7e-06	0.000136	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—REL—psoriasis	9.67e-06	0.000135	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ICAM1—psoriasis	9.62e-06	0.000135	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—VEGFA—psoriasis	9.61e-06	0.000135	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—VEGFA—psoriasis	9.59e-06	0.000134	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—psoriasis	9.55e-06	0.000134	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—STAT3—psoriasis	9.53e-06	0.000133	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—STAT3—psoriasis	9.51e-06	0.000133	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NDUFA5—psoriasis	9.43e-06	0.000132	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFIH1—psoriasis	9.39e-06	0.000131	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NDUFA5—psoriasis	9.38e-06	0.000131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CRP—psoriasis	9.36e-06	0.000131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NFKB1—psoriasis	9.35e-06	0.000131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—IL6—psoriasis	9.31e-06	0.00013	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	9.11e-06	0.000128	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HLA-B—psoriasis	9.04e-06	0.000127	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD8A—psoriasis	9.02e-06	0.000126	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—TYK2—psoriasis	9.01e-06	0.000126	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—IL6—psoriasis	9.01e-06	0.000126	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SOCS1—psoriasis	8.97e-06	0.000126	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DRB1—psoriasis	8.96e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-C—psoriasis	8.9e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SOCS1—psoriasis	8.87e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TNFAIP3—psoriasis	8.79e-06	0.000123	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.79e-06	0.000123	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.74e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL6—psoriasis	8.74e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—CP—psoriasis	8.71e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-B—psoriasis	8.68e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PPARG—psoriasis	8.62e-06	0.000121	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—psoriasis	8.6e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ICAM1—psoriasis	8.6e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	8.58e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—psoriasis	8.56e-06	0.00012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NFKBIA—psoriasis	8.53e-06	0.000119	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NDUFA5—psoriasis	8.42e-06	0.000118	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—psoriasis	8.41e-06	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	8.31e-06	0.000116	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NFKB1—psoriasis	8.29e-06	0.000116	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—APOE—psoriasis	8.27e-06	0.000116	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—LEP—psoriasis	8.27e-06	0.000116	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—psoriasis	8.23e-06	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—psoriasis	8.22e-06	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NDUFA5—psoriasis	8.22e-06	0.000115	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.17e-06	0.000114	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CD4—psoriasis	8.15e-06	0.000114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—NFKB1—psoriasis	8.15e-06	0.000114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-A—psoriasis	8.04e-06	0.000113	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SOCS1—psoriasis	8.02e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SOCS1—psoriasis	8.02e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2S1—psoriasis	8.02e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CRP—psoriasis	7.99e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2S1—psoriasis	7.97e-06	0.000112	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.85e-06	0.00011	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—TYK2—psoriasis	7.82e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NFKBIA—psoriasis	7.71e-06	0.000108	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NDUFA5—psoriasis	7.67e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—TYK2—psoriasis	7.65e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—TYK2—psoriasis	7.65e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.64e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	7.63e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	7.51e-06	0.000105	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—STAT3—psoriasis	7.45e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—psoriasis	7.41e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-E—psoriasis	7.39e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.35e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DRB1—psoriasis	7.35e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—CXCL8—psoriasis	7.33e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—STAT3—psoriasis	7.32e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IFNG—psoriasis	7.32e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NFKBIA—psoriasis	7.28e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	7.28e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCL20—psoriasis	7.24e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2S1—psoriasis	7.16e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.16e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CD4—psoriasis	7.07e-06	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ICAM1—psoriasis	7.05e-06	9.87e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NFKBIA—psoriasis	7e-06	9.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—TYK2—psoriasis	6.99e-06	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2S1—psoriasis	6.99e-06	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—psoriasis	6.94e-06	9.72e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—psoriasis	6.79e-06	9.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.67e-06	9.35e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—CXCL8—psoriasis	6.66e-06	9.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—CXCL8—psoriasis	6.66e-06	9.32e-05	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—psoriasis	6.66e-06	9.32e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—psoriasis	6.64e-06	9.3e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—APOE—psoriasis	6.62e-06	9.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—LEP—psoriasis	6.62e-06	9.27e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—psoriasis	6.56e-06	9.19e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—APOE—psoriasis	6.55e-06	9.16e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—LEP—psoriasis	6.55e-06	9.16e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNG—psoriasis	6.54e-06	9.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2S1—psoriasis	6.53e-06	9.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.51e-06	9.11e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—JUN—psoriasis	6.33e-06	8.86e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—psoriasis	6.32e-06	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TYK2—psoriasis	6.31e-06	8.84e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—psoriasis	6.31e-06	8.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SOCS1—psoriasis	6.17e-06	8.64e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NFKBIA—psoriasis	6.1e-06	8.54e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NFKB1—psoriasis	6.09e-06	8.53e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CARM1—psoriasis	6.06e-06	8.49e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TYK2—psoriasis	5.97e-06	8.35e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—LEP—psoriasis	5.92e-06	8.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—LEP—psoriasis	5.92e-06	8.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—APOE—psoriasis	5.92e-06	8.29e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—APOE—psoriasis	5.92e-06	8.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—psoriasis	5.87e-06	8.22e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.72e-06	8.01e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.67e-06	7.93e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—JUN—psoriasis	5.66e-06	7.92e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NFKBIA—psoriasis	5.52e-06	7.72e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NFKBIA—psoriasis	5.52e-06	7.72e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CXCL8—psoriasis	5.5e-06	7.7e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—psoriasis	5.47e-06	7.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—psoriasis	5.47e-06	7.66e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NFKB1—psoriasis	5.44e-06	7.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.42e-06	7.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—psoriasis	5.4e-06	7.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—psoriasis	5.26e-06	7.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.21e-06	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—psoriasis	5.2e-06	7.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—psoriasis	5.18e-06	7.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.16e-06	7.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—psoriasis	5.12e-06	7.16e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—JUN—psoriasis	5.11e-06	7.15e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TYK2—psoriasis	5.05e-06	7.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.04e-06	7.06e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TYK2—psoriasis	5e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NFKB1—psoriasis	4.92e-06	6.89e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—psoriasis	4.89e-06	6.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-A—psoriasis	4.88e-06	6.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—JUN—psoriasis	4.83e-06	6.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CARM1—psoriasis	4.81e-06	6.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	4.81e-06	6.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.73e-06	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—psoriasis	4.65e-06	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NFKB1—psoriasis	4.65e-06	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TYK2—psoriasis	4.52e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TYK2—psoriasis	4.52e-06	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.5e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NFKB1—psoriasis	4.46e-06	6.25e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—psoriasis	4.46e-06	6.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—psoriasis	4.46e-06	6.24e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—psoriasis	4.42e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—psoriasis	4.41e-06	6.17e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CXCL8—psoriasis	4.4e-06	6.16e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CXCL8—psoriasis	4.35e-06	6.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ICAM1—psoriasis	4.28e-06	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—psoriasis	4.28e-06	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NFKBIA—psoriasis	4.24e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.2e-06	5.88e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.18e-06	5.85e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—JUN—psoriasis	4.09e-06	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.06e-06	5.68e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—JUN—psoriasis	4.04e-06	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SOCS1—psoriasis	3.99e-06	5.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NFKB1—psoriasis	3.94e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CXCL8—psoriasis	3.93e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CXCL8—psoriasis	3.93e-06	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CARM1—psoriasis	3.92e-06	5.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CARM1—psoriasis	3.89e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NFKB1—psoriasis	3.89e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—psoriasis	3.82e-06	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.75e-06	5.25e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—psoriasis	3.74e-06	5.24e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—psoriasis	3.74e-06	5.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CAT—psoriasis	3.73e-06	5.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.66e-06	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—JUN—psoriasis	3.66e-06	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—JUN—psoriasis	3.66e-06	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.64e-06	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.58e-06	5.01e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—psoriasis	3.57e-06	5e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—psoriasis	3.54e-06	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—psoriasis	3.53e-06	4.95e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NFKB1—psoriasis	3.52e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NFKB1—psoriasis	3.52e-06	4.93e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—psoriasis	3.5e-06	4.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CARM1—psoriasis	3.5e-06	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TYK2—psoriasis	3.48e-06	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.42e-06	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—psoriasis	3.42e-06	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CARM1—psoriasis	3.41e-06	4.78e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—psoriasis	3.37e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.27e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—psoriasis	3.25e-06	4.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—psoriasis	3.19e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—psoriasis	3.19e-06	4.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CARM1—psoriasis	3.19e-06	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—psoriasis	3.16e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—psoriasis	3.16e-06	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—psoriasis	3.14e-06	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—psoriasis	3.09e-06	4.32e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.98e-06	4.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAT—psoriasis	2.96e-06	4.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—LEP—psoriasis	2.94e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—psoriasis	2.94e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HLA-A—psoriasis	2.94e-06	4.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—psoriasis	2.92e-06	4.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—psoriasis	2.9e-06	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—JUN—psoriasis	2.81e-06	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—psoriasis	2.75e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NFKBIA—psoriasis	2.74e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NFKB1—psoriasis	2.71e-06	3.79e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—psoriasis	2.7e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—psoriasis	2.56e-06	3.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PPARG—psoriasis	2.52e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—psoriasis	2.48e-06	3.47e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—psoriasis	2.47e-06	3.46e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—psoriasis	2.44e-06	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—psoriasis	2.43e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—psoriasis	2.41e-06	3.38e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—psoriasis	2.41e-06	3.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—psoriasis	2.41e-06	3.37e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—psoriasis	2.39e-06	3.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—psoriasis	2.3e-06	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TYK2—psoriasis	2.25e-06	3.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—psoriasis	2.21e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—psoriasis	2.21e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—psoriasis	2.15e-06	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—psoriasis	2.1e-06	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TYK2—psoriasis	2.1e-06	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PPARG—psoriasis	2e-06	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—psoriasis	1.96e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL8—psoriasis	1.96e-06	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—psoriasis	1.9e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—psoriasis	1.87e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—psoriasis	1.87e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—psoriasis	1.86e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—JUN—psoriasis	1.82e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NFKB1—psoriasis	1.75e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—psoriasis	1.7e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—psoriasis	1.67e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—psoriasis	1.63e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PPARG—psoriasis	1.63e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PPARG—psoriasis	1.62e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—psoriasis	1.59e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—psoriasis	1.57e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—psoriasis	1.52e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—psoriasis	1.47e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PPARG—psoriasis	1.45e-06	2.04e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PPARG—psoriasis	1.42e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PPARG—psoriasis	1.33e-06	1.86e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—psoriasis	1.2e-06	1.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—psoriasis	1.1e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—psoriasis	1.03e-06	1.44e-05	CbGpPWpGaD
